Recent studies have demonstrated that exosomes derived from BM‐MSCs can counteract IL‐1β‐induced NPC apoptosis by suppressing the NLRP3 inflammasome activation. The gene discussed is IL1B; the disease is nasopharyngeal carcinoma.